Share on facebook
Share on twitter
Share on linkedin

Sesija 8: Savremena dostignuća u istraživanju biomarkera

Drage koleginice i kolege,

Precizna medicina i rana dijagnostika danas zahtevaju mnogo više od praćenja izolovanih parametara. U okviru Naučnog programa 9. Kongresa farmaceuta Srbije sa međunarodnim učešćem, predstavljamo vam temu koja donosi suštinsku promenu u razumevanju, otkrivanju i praćenju bolesti kroz Sesiju 8.

“Savremena dostignuća u istraživanju biomarkera”

Otkrivanje pouzdanih indikatora za ranu procenu rizika i praćenje terapijskog odgovora zahteva visoku tačnost, specifičnost i, pre svega, holistički pristup pacijentu. Upravo zato multimarkerski paneli danas predstavljaju optimalan model, kako u nauci, tako i u kliničkoj praksi. Ova sesija pruža dublji uvid u primenu naprednih multi-omics metoda i mašinskog učenja u prepoznavanju specifičnih molekularnih obrazaca. Poseban fokus biće na novim biomarkerima za vodeće javnozdravstvene izazove, poput kardiovaskularnih bolesti i MASLD-a, kao i na inovativnim pokazateljima od presudnog značaja za praćenje toka i unapređenje ishoda trudnoće.

Pogledajte galeriju ispod kako biste se upoznali sa istaknutim stručnjacima i rasporedom predavanja u okviru ove sesije!

Precision medicine and early diagnostics today require more than simply monitoring isolated parameters. As part of the Scientific Program of the 9th Serbian Congress of Pharmacy with International Participation, Session 8 presents a topic that marks a fundamental shift in how we understand, detect, and monitor disease

” Advances in biomarker science”

Discovering reliable indicators for early risk assessment and therapeutic monitoring demands high accuracy, specificity, and, above all, a holistic approach to the patient. For this reason, multi-marker panels represent the optimal model in both research and clinical practice today. This session provides deeper insight into the application of advanced multi-omics methods and machine learning for identifying specific molecular signatures. Special focus will be placed on novel biomarkers for major public health challenges, such as cardiovascular diseases and MASLD, as well as on innovative indicators crucial for monitoring and improving pregnancy outcomes.

Swipe through the gallery below to meet our experts and view the detailed lecture schedule for this session!

Vamtam
Vamtam

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor